Crossmark

Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan

Crossref DOI link: https://doi.org/10.1007/s12325-023-02564-4

Published Online: 2023-06-12

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hosogaya, Naoki https://orcid.org/0000-0002-3229-2277
Takazono, Takahiro https://orcid.org/0000-0002-0696-5386
Kurazono, Kenji https://orcid.org/0000-0003-1678-0446
Hiroi, Shinzo https://orcid.org/0000-0002-0015-4793
Iwasaki, Kosuke

Takeshima, Tomomi https://orcid.org/0000-0002-0572-5145
Ha, Chise

Mukae, Hiroshi https://orcid.org/0000-0002-1429-5706
Funding

Funding for this research was provided by:

Shionogi
License Information

Text and Data Mining valid from 2023-06-12

Version of Record valid from 2023-06-12
More Information

Article History

Received: 27 March 2023

Accepted: 18 May 2023

First Online: 12 June 2023